$224.59
Down 0.99% · live quote Sep 4, 2026
Market cap
$21.90B
Market cap $21.90B
Adjust assumptions
Adjust the usable peer mix to see how each valuation multiple moves the blended fair value.
Peer-implied fair value
$168.17
Blended value per share under the current mix.
Current price
$224.59
Sep 04, 2026
Peer gap
-25.1%
Peers imply 25.1% downside
Weighting mixer
Value contribution
4 peers →Price / Sales
$9.50B
Price / Earnings
$6.89B
Price / Sales
$19.00B
Price / Earnings
$13.79B
Equal-weight baseline
Premium 0.0%The simple average of every usable peer method, before your weighting adjustments.
Baseline equity value
$16.40B
Baseline / share
$168.17
Relative valuation prices this company against what the market already pays for its peers. For a cash-flow view that does not inherit peer sentiment, open the intrinsic model.
Spreadsheet data
Audit the saved peer set and the method inputs behind the blended fair value.
The saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market cap | Enterprise value | Revenue | EBITDA | Net income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
JNJ JOHNSON & JOHNSON FY ended Feb 06, 2026 | $275.23 | $663.28B | — | $94.19B | $37.95B | $26.80B | 24.95x | 7.04x | — |
BAX BAXTER INTERNATIONAL INC FY ended Feb 05, 2026 | $25.83 | $13.35B | — | $11.24B | $709.00M | -$957.00M | -13.81x | 1.19x | — |
BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $184.74 | $50.32B | — | $21.84B | $4.81B | $1.68B | 31.74x | 2.30x | — |
ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $98.07 | $18.71B | — | $8.23B | $1.92B | $705.10M | 27.63x | 2.27x | — |
JNJ
JOHNSON & JOHNSON
$275.23
$663.28B
—
$94.19B
$37.95B
24.95x
7.04x
—
Cap $663.28BEV —Rev $94.19BEBITDA $37.95BP/E 24.95xP/S 7.04xEV/EBITDA —
BAX
BAXTER INTERNATIONAL INC
$25.83
$13.35B
—
$11.24B
$709.00M
-13.81x
1.19x
—
Cap $13.35BEV —Rev $11.24BEBITDA $709.00MP/E -13.81xP/S 1.19xEV/EBITDA —
BDX
BECTON DICKINSON & CO
$184.74
$50.32B
—
$21.84B
$4.81B
31.74x
2.30x
—
Cap $50.32BEV —Rev $21.84BEBITDA $4.81BP/E 31.74xP/S 2.30xEV/EBITDA —
ZBH
ZIMMER BIOMET HOLDINGS, INC.
$98.07
$18.71B
—
$8.23B
$1.92B
27.63x
2.27x
—
Cap $18.71BEV —Rev $8.23BEBITDA $1.92BP/E 27.63xP/S 2.27xEV/EBITDA —
Which peer averages feed the weighted fair value, and which methods are excluded.
| Method | Type | Avg. multiple | Coverage | Implied equity value | Fair value / share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | — | 0/4 | — | — | No saved peers have usable coverage for this method. |
Price / Sales PSActive | Equity Multiple | 3.20x | 4/4 | $19.00B | $194.91 | Included in the active peer mix. |
Price / Earnings PEActive | Equity Multiple | 17.63x | 4/4 | $13.79B | $141.43 | Included in the active peer mix. |
EV / EBITDA
EV · Enterprise Multiple
Avg. multiple
—
Coverage
0/4
Implied equity value
—
Fair value / share
—
No saved peers have usable coverage for this method.
Price / Sales
PS · Equity Multiple
Avg. multiple
3.20x
Coverage
4/4
Implied equity value
$19.00B
Fair value / share
$194.91
Included in the active peer mix.
Price / Earnings
PE · Equity Multiple
Avg. multiple
17.63x
Coverage
4/4
Implied equity value
$13.79B
Fair value / share
$141.43
Included in the active peer mix.
